Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Evaluation of the Relationship of MPV, RDW and PVI Parameters with Disease Severity in Covid-19 Patients ; Procjena odnosa srednjeg volumena trombocita, širine distribucije eritrocita i indeksa volumena trombocita s težinom bolesti kod bolesnika s COVID-19

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      Sestre Milosrdnice University hospital and Institute of Clinical Medical Research
    • الموضوع:
      2021
    • Collection:
      Hrčak - Portal of scientific journals of Croatia / Portal znanstvenih časopisa Republike Hrvatske
    • نبذة مختصرة :
      Coronavirus was first detected in three severe pneumonia cases in Wuhan, China, in December 2019. Studies on red cell distribution width (RDW-CV) and mean platelet volume (MPV) laboratory parameters, which can be examined in complete blood count in COVID-19 patients, are still very limited. However, to the best of our knowledge, there are no studies examining the relationship between platelet volume index (PVI) and disease severity in COVID-19 patients, which was evaluated in this study. The aim of this study was to evaluate the relationship of disease severity in COVID-19 patients with their MPV, RDW, and PVI parameters. The study included 92 COVID-19 patients as a study group and 84 healthy individuals as control group. All laboratory data and radiological images were scanned retrospectively from patient files and hospital information system. Evaluation of the RDW-CV and MPV blood parameters, and PVI measured in COVID-19 patients yielded statistically significant differences according to the disease severity. We suggest that RDW-CV and PVI, evaluated within the scope of the study, may be the parameters that should be considered in the early diagnosis of the disease, from the initial stages of COVID-19. In addition, we think that the RDW-CV and MPV laboratory parameters, as well as PVI, which all are simple, inexpensive and widely used hematologic tests, can be used as important biomarkers in determining COVID-19 severity and mortality. ; Koronavirus je prvi put otkriven kod tri slučaja teške upale pluća u Wuhanu, Kina u prosincu 2019. godine. Istraživanja laboratorijskih parametara širine distribucije eritrocita (RDW-CV) i srednjeg volumena trombocita (MPV) koji se mogu testirati unutar kompletne krvne slike kod bolesnika s COVID-19 još uvijek su vrlo ograničena. Međutim, prema našim saznanjima, nema istraživanja koja bi se bavila odnosom indeksa volumena trombocita (PVI) i težine bolesti kod ovih bolesnika, a upravo to smo ispitivali u našem istraživanju. Cilj studije bio je procijeniti odnos težine bolesti u ...
    • Relation:
      https://doi.org/10.20471/acc.2021.60.01.15; https://hrcak.srce.hr/259900
    • الرقم المعرف:
      10.20471/acc.2021.60.01.15
    • الدخول الالكتروني :
      https://doi.org/10.20471/acc.2021.60.01.15
      https://hrcak.srce.hr/259900
    • Rights:
      info:eu-repo/semantics/openAccess ; https://creativecommons.org/licenses/by-nc-nd/4.0/
    • الرقم المعرف:
      edsbas.7C5280B8